Journal of Personalized Medicine

Journal of Personalized Medicine (ISSN 2075-4426; CODEN: JPMOB3) is an international peer-reviewed open access journal on personalized medicine published quarterly online by MDPI.
  • Open Access—free for readers, with article processing charges (APC) paid by authors or their institutions.
  • High Visibility: Covered by the Science Citation Index Expanded (SCIE - Web of Science). Citations available in PubMed; full-text archived in PubMed Central. Indexed in Scopus.
  • CiteScore 2018 (Scopus): 3.59, which equals rank 41/206 (Q1) in 'Medicine (miscellaneous).'
  • Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 19 days after submission; acceptance to publication is undertaken in 4.1 days (median values for papers published in this journal in the first half of 2020).
  • Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
Impact Factor: 4.433 (2019)
Add your e-mail address to receive forthcoming issues of this journal:
Special Issue in JPM
Understanding Neuromuscular Health and Disease: Advances in Genetics, Omics, and Molecular Function Guest Editors: William Duddy, Stephanie Duguez
Deadline: 31 October 2020
Special Issue in JPM
Molecular Pathology of Cancer: The Past, the Present, and the Future Guest Editor: Leonhard Müllauer
Deadline: 15 November 2020
Special Issue in JPM
The Interface between Human Physiology and Medical Device Development Guest Editor: Leo Quinlan
Deadline: 30 November 2020
Special Issue in JPM
Precision Approach to Glioblastoma Treatment Guest Editor: Madan M. Kwatra
Deadline: 10 December 2020
Topical Collection in JPM
Personalised Medicine–Bringing Innovation to the Healthcare System Collection Editors: Denis Horgan, Gordon McVie
Topical Collection in JPM
Genomic Medicine and Policy Collection Editors: Christine Lu, Kurt Christensen, Nina Sperber
Back to TopTop